Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 53 (2019): Issue 2 (June 2019)
Open Access
A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort
Stefan Janssen
Stefan Janssen
,
Heinke C Hansen
Heinke C Hansen
,
Liesa Dziggel
Liesa Dziggel
,
Steven E Schild
Steven E Schild
and
Dirk Rades
Dirk Rades
| May 08, 2019
Radiology and Oncology
Volume 53 (2019): Issue 2 (June 2019)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
May 08, 2019
Page range:
219 - 224
Received:
Feb 12, 2019
Accepted:
Mar 27, 2019
DOI:
https://doi.org/10.2478/raon-2019-0020
© 2019 Stefan Janssen, Heinke C Hansen, Liesa Dziggel, Steven E Schild, Dirk Rades, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Stefan Janssen
Department of Radiation Oncology, University Hospital Lubeck
Lubeck, Germany
Medical Practice for Radiotherapy and Radiation Oncology
Hannover, Germany
Heinke C Hansen
Department of Radiation Oncology, University Hospital Lubeck
Lubeck, Germany
Liesa Dziggel
Department of Radiation Oncology, University Hospital Lubeck
Lubeck, Germany
Steven E Schild
Department of Radiation Oncology, Mayo Clinic Scottsdale
Arizona, U.S.A.
Dirk Rades
Department of Radiation Oncology, University Hospital Lubeck
Lubeck, Germany